CRISPR

# CRISPR

Who / What

**CRISPR** is a family of DNA sequences found in the genomes of prokaryotic organisms like bacteria and archaea. These sequences are derived from fragments of bacteriophages (viruses that infect bacteria) and serve as an adaptive immune system to recognize and neutralize similar viral DNA during future infections.

Background & History

CRISPR was first discovered in the late 1980s within bacterial genomes, where it was initially thought to be a repetitive DNA sequence. Later research revealed its role in prokaryotic immunity against phages. The full significance of CRISPR was only fully understood after advances in molecular biology and genome editing technologies in the early 2000s. Key milestones include:

Identification of CRISPR-Cas systems as adaptive immune mechanisms.

Development of CRISPR-Cas9 as a powerful tool for gene editing in eukaryotic cells.

Why Notable

CRISPR has revolutionized genetic research, enabling precise modifications to DNA sequences with unprecedented efficiency and specificity. Its applications span from basic biological studies to potential medical treatments, including cancer therapies and disease eradication efforts. The technology has also sparked debates on ethical implications, such as gene editing in humans and biosecurity concerns.

In the News

CRISPR remains a rapidly evolving field with ongoing breakthroughs, particularly in its clinical translation. Recent developments include FDA approvals for CRISPR-based treatments (e.g., Casgevy for sickle cell disease), expanding its medical applications while continuing to drive innovation in synthetic biology and biotechnology. Its global impact underscores its role as a cornerstone of modern genetic engineering.

Key Facts

**Type:** Organization (scientific discovery/technological system)

**Also known as:**

Clustered Regularly Interspaced Short Palindromic Repeats

CRISPR-Cas system (when referring to specific adaptive immune mechanisms)

**Founded / Born:** Emerged naturally in prokaryotic genomes (~1987, though later refined in the early 2000s)

**Key dates:**

~1987: Initial discovery of repetitive sequences in bacteria.

Early 2000s: Identification of CRISPR-Cas systems as adaptive immunity mechanisms.

2012–2013: Development of CRISPR-Cas9 by Feng Zhang and Emmanuelle Charpentier (Nobel Prize co-recipient, 2020).

**Geography:** Originated in bacterial/archaeal genomes worldwide; now global research focus.

**Affiliation:**

Primarily associated with microbiology, genetics, and biotechnology fields.

Key institutions: Broad Institute, MIT, Harvard University (early CRISPR-Cas9 development).

Links

[Wikipedia](https://en.wikipedia.org/wiki/CRISPR)

Sources

• 🔗 Wikipedia

CRISPR (; acronym for clustered regularly interspaced short palindromic repeats) is a family of DNA sequences found in the genomes of prokaryotic organisms such as bacteria and archaea. Each sequence within an individual prokaryotic CRISPR is derived from a DNA fragment of a bacteriophage that had previously infected the prokaryote or one of its ancestors. These sequences are used to detect and destroy DNA from similar bacteriophages during subsequent infections.